Bonsity Injection

Brand Name: Bonsity

Molecule: Teriparatide

Strength: 600 mcg

Quantity: 1 Pre-filled Pen

Form: Injection

Packaging Type: Syringe

Manufacturer/Marketed By: Pfenex Inc

Country of Origin: U.S

Image	Product	Manufacturer / Marketed By	Price
	Gemtide Injection	Alkem Laboratories	Ask for Price
	Forteo Injection	Eli Lilly And Company	Ask for Price

Description

Introducing Bonsity Injection, a clinically proven treatment designed to combat osteoporosis in both postmenopausal women and men with primary or hypogonadal osteoporosis. Formulated with teriparatide, a parathyroid hormone analog (PTH 1-34), Bonsity is expertly crafted for subcutaneous use, ensuring effective delivery and results. Since its initial approval in the U.S. in 1987, Bonsity has been a trusted solution for those at high risk of fractures. It is specifically indicated for postmenopausal women experiencing osteoporosis, particularly for those who have faced challenges with other osteoporosis therapies. Likewise, it helps increase bone mass in men with osteoporosis who are at high fracture risk or have been intolerant to alternative treatments.

FAQ

What is Bonsity and how does it work?+

Bonsity is a parathyroid hormone analog (PTH 1-34) approved for the treatment of osteoporosis. It stimulates bone formation, increases bone mass, and reduces the risk of fractures in high-risk patients.

What are the potential side effects of Bonsity?+

Common side effects of Bonsity may include nausea, injection site reactions, and leg cramps. Patients should consult their healthcare provider for a complete list of possible side effects.

How long can a patient use Bonsity for osteoporosis treatment?+

Bonsity is generally prescribed for a maximum duration of two years, after which patients should be evaluated for ongoing treatment options and management of osteoporosis.

Related Products